πŸ•΅οΈ Neuroone Medical Technologies Corp ($NMTC)

SEC insider & ownership activity, last 12 months Β· CIK 1500198 Β· every row links its SEC filing

Over the last 12 months insiders sold $55K against $737K of open-market buying. David J. Wambeke bought $737K in discretionary trades (Mar–Aug). 2 red-flag 8-Ks in the window, most recently Restatement (4.02), May 21, 2026.

Oct 2025: net +$0 Nov 2025: net +$0 Dec 2025: net +$0 Jan 2026: net +$0 Feb 2026: net +$0 Mar 2026: net +$647K Apr 2026: net +$0 May 2026: net +$0 Jun 2026: net -$32K Jul 2026: net +$0 Aug 2026: net +$67K Sep 2026: net +$0
Monthly net open-market insider flow, last 12 months (up = net buying)

Insider flow

1 buyer, $737K (2 lots) Β· 1 seller, $55K (6 lots)

InsiderBuysBoughtSellsSoldLast
David J. Wambeke2$737K 0–Aug 27, 2026
Christianson Mark0– 6$55KJun 30, 2026

5%+ holders

HolderStakeClassScheduleEvent
Merchant Adventure Fund, L.P. 13.6% 13GFeb 4, 2025 filing β†—
Brian Pratt 12.5% 13GJul 14, 2026 filing β†—
Barbara Pratt 12.5% 13GJul 14, 2026 filing β†—
Bleichroeder LP 8.0% 13GAug 14, 2025 filing β†—
Bleichroeder Holdings LLC 8.0% 13GAug 14, 2025 filing β†—
Andew Gundlach 8.0% 13GAug 14, 2025 filing β†—

Planned insider sales (Form 144)

SellerPlannedApprox. sale date
Christianson Mark$33KJun 30, 2026 filing β†—
Christianson Mark$25KMar 9, 2026 filing β†—

Material events (8-K)

ItemEvent date
Other events (8.01)Aug 27, 2026 filing β†—
Financial Statements and Exhibits (9.01)Aug 27, 2026 filing β†—
Earnings (2.02)Aug 13, 2026 filing β†—
Financial Statements and Exhibits (9.01)Aug 13, 2026 filing β†—
Other events (8.01)Jun 12, 2026 filing β†—
Financial Statements and Exhibits (9.01)Jun 12, 2026 filing β†—
Restatement (4.02)May 21, 2026 filing β†—
Reg FD disclosure (7.01)May 21, 2026 filing β†—
Financial Statements and Exhibits (9.01)May 21, 2026 filing β†—
Earnings (2.02)May 12, 2026 filing β†—
Financial Statements and Exhibits (9.01)May 12, 2026 filing β†—
Other events (8.01)Apr 30, 2026 filing β†—
Officer/director changes (5.02)Apr 24, 2026 filing β†—
Financial Statements and Exhibits (9.01)Apr 24, 2026 filing β†—
Charter/bylaw changes (5.03)Apr 14, 2026 filing β†—
Financial Statements and Exhibits (9.01)Apr 14, 2026 filing β†—
Officer/director changes (5.02)Apr 3, 2026 filing β†—
Shareholder vote (5.07)Apr 3, 2026 filing β†—
Financial Statements and Exhibits (9.01)Apr 3, 2026 filing β†—
Other events (8.01)Feb 25, 2026 filing β†—
Earnings (2.02)Feb 17, 2026 filing β†—
Financial Statements and Exhibits (9.01)Feb 17, 2026 filing β†—
Officer/director changes (5.02)Dec 18, 2025 filing β†—
Reg FD disclosure (7.01)Dec 18, 2025 filing β†—
Financial Statements and Exhibits (9.01)Dec 18, 2025 filing β†—
Earnings (2.02)Dec 17, 2025 filing β†—
Financial Statements and Exhibits (9.01)Dec 17, 2025 filing β†—
Delisting notice (3.01)Nov 4, 2025 filing β†—
Earnings (2.02)Oct 6, 2025 filing β†—
Other events (8.01)Oct 6, 2025 filing β†—